To answer your question, I'll answer from the industry standpoint and then let Jim answer as a producer.
One of the things we've done, as the Canadian soybean industry, is that we take a whole industry approach. I'll give Japan as an example of an export market.
Japan is the Canadian soybean industry's largest market. It's a premium market for Canadian soybeans. It currently has a 5% threshold. As the Canadian soybean industry, we work together with our researchers who develop the varieties, as well as the exporters who are the ones on the ground, making the sales, and determining what the customers want.
That 5% is a base. Many times in Japan our customers will request higher specs than that. So we actually will supply varieties or product based to the exact specification of our customers, whether it be for natto production, whether it be for tofu production, whether it be for miso production. We will produce and we will ship the beans in a way that is usable by our customers. So we will meet their needs. It's not hard for us to meet those thresholds as long as the biotech trait is approved; we have that. If it's an unapproved event, we can't guarantee zero.
So that's something that's very important to us: to ensure that the approval processes are harmonized to ensure that our growers and our industry can take advantage of those opportunities in Japan and in the EU, where they're more sensitive to biotechnology.